Role of Kiratatikta Churna in the management of Amavata(Rheumatoid Arthritis)
Phase 4
- Conditions
- Health Condition 1: M069- Rheumatoid arthritis, unspecified
- Registration Number
- CTRI/2023/05/052849
- Lead Sponsor
- Ch. Brahm Prakash Ayurved Charak Sansthan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed Patients Of Rheumatoid Arthritis as per 2010 ACR/ EULAR Criteria
Patients having Samanyalakshana and Pravridhhalakshana of Amavata as per Madhavnidana
Patients willing to give consent for the study
Exclusion Criteria
Pregnant women and Lactating mothers
All other forms of Arthritis
Patients having co morbidities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in VAS score and DAS28 Score is expected and will be assessed on 0, 15th, 30th and 45th day.Timepoint: 45 Days
- Secondary Outcome Measures
Name Time Method The study will provide cost effective, safe drug with lesser side effectsTimepoint: 6 months